Yerly S - Search Results

1

Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report.

Schibler M, Vetter P, Cherpillod P, Petty TJ, Cordey S, Vieille G, Yerly S, Siegrist CA, Samii K, Dayer JA, Docquier M, Zdobnov EM, Simpson AJH, Rees PSC, Sarria FB, Gasche Y, Chappuis F, Iten A, Pittet D, Pugin J, Kaiser L. Schibler M, et al. Among authors: yerly s. Lancet Infect Dis. 2015 Sep;15(9):1034-1040. doi: 10.1016/S1473-3099(15)00229-7. Epub 2015 Jul 19. Lancet Infect Dis. 2015. PMID: 26201298

2

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.

Yerly S, Chamot E, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1992 Aug;166(2):269-76. doi: 10.1093/infdis/166.2.269. J Infect Dis. 1992. PMID: 1353103

3

Response of HIV RNA to didanosine as a predictive marker of survival.

Yerly S, Kaiser L, Mermillod B, Baumberger C, Hirschel B, Perrin L. Yerly S, et al. AIDS. 1995 Feb;9(2):159-63. AIDS. 1995. PMID: 7718186

4

Foscarnet decreases human immunodeficiency virus RNA.

Kaiser L, Perrin L, Hirschel B, Furrer H, Von Overbeck J, Olmari M, Yerly S. Kaiser L, et al. Among authors: yerly s. J Infect Dis. 1995 Jul;172(1):225-7. doi: 10.1093/infdis/172.1.225. J Infect Dis. 1995. PMID: 7797916 Clinical Trial.

5

Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.

Yerly S, Kaiser L, Baumberger C, Hirschel B, Perrin LH. Yerly S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):358-64. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882100

6

Mother to child transmission of zidovudine-resistant HIV-1.

Siegrist CA, Yerly S, Kaiser L, Wyler CA, Perrin L. Siegrist CA, et al. Among authors: yerly s. Lancet. 1994 Dec 24-31;344(8939-8940):1771-2. Lancet. 1994. PMID: 7997023 No abstract available.

7

Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group.

Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L. Galetto-Lacour A, et al. Among authors: yerly s. J Infect Dis. 1996 Jun;173(6):1388-93. doi: 10.1093/infdis/173.6.1388. J Infect Dis. 1996. PMID: 8648210

8

Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy.

Perrin L, Yerly S, Marchal F, Schockmel GA, Hirschel B, Fox CH, Pantaleo G. Perrin L, et al. Among authors: yerly s. J Infect Dis. 1998 Jun;177(6):1497-501. doi: 10.1086/515303. J Infect Dis. 1998. PMID: 9607825

9

A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher HC, Bernasconi E, Sudre P, Leduc D, Yerly S, Perrin LH, Hirschel B. Rutschmann OT, et al. Among authors: yerly s. AIDS. 1998 May 28;12(8):F71-7. doi: 10.1097/00002030-199808000-00003. AIDS. 1998. PMID: 9631134 Clinical Trial.

10

Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

Lorenzi P, Opravil M, Hirschel B, Chave JP, Furrer HJ, Sax H, Perneger TV, Perrin L, Kaiser L, Yerly S. Lorenzi P, et al. Among authors: yerly s. AIDS. 1999 Feb 4;13(2):F17-21. doi: 10.1097/00002030-199902040-00001. AIDS. 1999. PMID: 10202819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

509 results

Search Page